Get Level 2

Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE
REMOVE ADS
REMOVE ADS

Latest Share Chat

  2. Share Prices
  3. Graft Polymer PLC Share Price
  4. Graft Polymer PLC Share Regulatory News
  5. AGM Notice

Pin to quick picksGraft Polymer PLC Regulatory News (GPL)

Graft Polymer PLC Information
  • There is currently no data for GPL

AGM Notice

4 Jul 2023 07:00

RNS Number : 8313E
Graft Polymer (UK) PLC
04 July 2023
 

 

GRAFT POLYMER AGM NOTICE FOR 27 JULY 2023

 

 

 

 

Graft Polymer (UK) plc (LSE: GPL), Graft Polymer, (LON:GPL) the specialty chemicals company offering modified polymer solutions for refiners, compounders and processors, announces that the Company has sent a notice to shareholders convening the Annual General Meeting of the Company (the "Notice") to be held at the offices of Memery Crystal, 165 Fleet Street, London EC4A 2DY on 27 July 2023 at 11:30 a.m. The Notice is available on the Company's website at www.graftpolymer.com.

 

 

 

ENDS

 

 

 

 

For further information, visit www.graftpolymer.com ,follow on Twitter @PolymerLtd or contact:

 

Graft Polymer (UK) Plc

Roby Zomer, Non Executive Chairman Via Flagstaff

Yifat Steur, CFO and Executive Chairman

 

Turner Pope Investments Tel:+44 (0) 20 3657 0050

James Pope

Andy Thaker

 

Flagstaff Strategic and Investor Communications Tel + 44 (0) 207 129 1474

Tim Thompson

Mark Edwards

Alison Allfrey

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NOAUPUMGMUPWPGW
12
Date   Source Headline
27th Dec 20237:00 amRNSGM Notice 8th January 2024
22nd Dec 20237:00 amRNSPlacing of New Ordinary Shares
9th Oct 20237:00 amRNSPivotal Agreement within European Consortium
27th Sep 20237:02 amRNSUpdated Investor Presentation
27th Sep 20237:00 amRNSInterim Financial Results
11th Sep 20237:00 amRNSR&D Agreement with Slovenian Faculty
4th Sep 20237:00 amRNSR&D and supply agreement with FORPET BALTIC
30th Aug 20237:00 amRNSR&D Supply Agreement Signed
23rd Aug 20237:00 amRNSGraft Bio signs manufacturing services agreement
27th Jul 202311:54 amRNSResult of AGM
26th Jul 20237:00 amRNSDistribution agreement with US Inter-Technologies
6th Jul 20237:00 amRNSNew R&D and Supply Agreement with Gabriel Chemie
5th Jul 20237:00 amRNSOperational Update
4th Jul 20237:00 amRNSAGM Notice
16th May 20232:08 pmRNSDirector Share Purchase
27th Apr 20237:00 amRNSFinal Results
21st Mar 20237:00 amRNSGraftBio - MGC Pharma Update
20th Mar 20237:00 amRNSCorporate Presentation
9th Feb 20237:00 amRNSUpdate: New Product Lines & Facility Expansion
30th Sep 20227:00 amRNSInterim Results
20th Sep 20227:00 amRNSNew Corporate Presentation
18th Aug 202210:00 amRNSFirst Commercial Purchase Order for GraftBio
28th Jul 202212:30 pmRNSResult of AGM
4th Jul 20224:50 pmRNSNotice of AGM
29th Jun 20227:00 amRNSFinal Results
20th Jun 20227:00 amRNSOperational Update
17th Jun 20227:00 amRNSGraftBio IP – MGC Pharma Update
18th May 20227:00 amRNSDirector Share Purchase
12th May 20227:00 amRNSHACCP Certificate Enabling Access to B2C Market
22nd Apr 20227:17 amRNSGrant of patents
7th Apr 20227:00 amRNSPre-payment for equipment
6th Apr 202211:50 amRNSDirector/PDMR Shareholding
21st Feb 20227:00 amRNSUpdate on Operations
15th Feb 20227:00 amRNSChange of Year End
25th Jan 20227:00 amRNSBusiness Update
11th Jan 20227:00 amRNSInvestor Presentation
6th Jan 20227:00 amRNSAdmission to Main Market, First Day of Dealings
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Recently viewed
AST
Ascent Resources
LSE
-10.53%
GAMA
Gamma Communications
LSE
-2.82%
JUS
JUS.L
LSE
0.00%
PMG
Parkmead
LSE
5.41%
SOI
Schroders
LSE
-2.52%
Trending
QHE
Quantum Helium
LSE
-1.67%
PREM
Premier African Minerals
LSE
7.50%
EZJ
easyJet
LSE
2.24%
AVCT
Avacta Group
LSE
0.28%
KEFI
Kefi Gold & Copper
LSE
-0.57%